Fujirebio Diagnostics
-
Malvern Biotechnology Company Develops New Blood Test to Diagnose Alzheimer’s
Malvern biotechnology company Fujirebio Diagnostics has developed a revolutionary new test to diagnose Alzheimer’s disease, writes Harold Brubaker for The Philadelphia Inquirer. Previously, FDA-approved Alzheimer’s…
-
Malvern Medical Manufacturer Cleared for First-of-Its-Kind Alzheimer’s Blood Test
A first-of-its-kind blood test developed by Malvern-based Fujirebio Diagnostics to help diagnose Alzheimer’s disease has received clearance from the U.S. Food and Drug Administration, writes…
-
Malvern-Based Medical Equipment Company Backed by FDA for Its Diagnostic Test for Alzheimer’s
Malvern-based Fujirebio Diagnostics has received marketing authorization from the FDA for its diagnostic test for Alzheimer’s disease, writes John George for the Philadelphia Business Journal. …
-
Medical Device Tax Is Killing Potential Jobs Says Fujirebio Diagnostics
Obamacare’s new-in-2013 medical device tax is killing the potential for new jobs at medical device developers like Malvern’s Fujirebio Diagnostics, according to a Newsworks report.…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
